McCulloch Mignon I, Kala Udai K
Department of Paediatrics, Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa,
Pediatr Nephrol. 2015 Apr;30(4):541-8. doi: 10.1007/s00467-014-2782-y. Epub 2014 Apr 2.
Renal transplantation is being performed in adult human immunodeficiency virus (HIV)-positive patients and increasingly in paediatric patients as well. A multidisciplinary team involving an infectious disease professional is required to assist with HIV viral-load monitoring and in choosing the most appropriate highly active antiretroviral therapy (HAART). Drug interactions complicate immunosuppressant therapy and require careful management. The acute rejection rates appear to be similar in adults to those in noninfective transplant recipients. Induction with basiliximab and calcineurin-based immunosuppression appears to be safe and effective in these recipients. Prophylaxis is advised for a variety of infections and may need life-long administration, especially in children. Organ shortage remains a significant problem, and kidneys from deceased HIV-positive donors have been used successfully in a small study population. Overall, with careful planning and close follow-up, successful renal transplantation for paediatric HIV-infected recipients is possible.
成人人类免疫缺陷病毒(HIV)阳性患者正在接受肾移植,儿科患者接受肾移植的情况也越来越多。需要一个由传染病专业人员组成的多学科团队来协助进行HIV病毒载量监测,并选择最合适的高效抗逆转录病毒疗法(HAART)。药物相互作用使免疫抑制治疗变得复杂,需要谨慎管理。成人的急性排斥率似乎与非感染性移植受者相似。在这些受者中,使用巴利昔单抗诱导和基于钙调神经磷酸酶的免疫抑制似乎是安全有效的。建议对多种感染进行预防,可能需要终身给药,尤其是在儿童中。器官短缺仍然是一个重大问题,在一小部分研究人群中,已成功使用来自已故HIV阳性供体的肾脏。总体而言,通过精心规划和密切随访,儿科HIV感染受者有可能成功进行肾移植。